Biological therapy in early rheumatoid arthritis: Efficacy in disease remission

Vista sencilla de ítem
dc.contributor.authorCamargo Barrios, Carmenza Beatriz
dc.contributor.authorVillarreal Fernández, Jorge Eliécer
dc.contributor.authorQuintana, Gerardo
dc.date.accessioned2020-07-10T16:03:48Z
dc.date.available2020-07-10T16:03:48Z
dc.date.issued2020
dc.description.abstractEULAR 2010), que recibieron terapia biológica en monoterapia o combinada con otros fármacos antirreumáticos modificadores de la enfermedad (FARME) y fueron incluidos en estudios clínicos controlados aleatorizados.Resultados_ La revisión sistemática de la literatura identificó 978 estudios potencialmente relevantesspa
dc.description.abstractenglishRheumatoid arthritis is a chronic, systemic inflammatory disease, with a world prevalence of around 1%. The course of the disease may be changed by using synthetic and/or biological disease-modifying antirheumatic drugs alone or in combination. This review assessed whether the use of biological agents in early rheumatoid arthritis can lead to disease remission. Objective: To evaluate the efficacy of biological therapies in inducing remission in patients with early rheumatoid arthritis. Methods: Type of study: systematic review of the literature. A systematic search of the literature was made in specialized electronic health databases: PubMed, Embase, Cochrane, LILACS, gray literature (doctoral theses, congresses, entity reports, unpublished works) and manual search (Secondary searches of the studies cited in the selected articles). Inclusion criteria: Patients older than 18 years with early rheumatoid arthritis (clinical course less than 12 months) according to criteria of the American College of Rheumatology / European League against Rheumatism (ACR 1987, ACR / EULAR 2010), who received biological therapy Monotherapy or combined with other disease modifying antirheumatic drugs (DMARDs) and were included in randomized controlled trials. Results: The systematic review of the literature identified 978 potentially relevant studies. Of the 86 that were chosen for a thorough evaluation, 68 articles were excluded. A qualitative and quantitative analysis of the remaining 18 studies was performed. A high risk of bias was identified in the studies evaluated and synthesis of the evidence did not show differences in the outcome of remission using biological therapy alone or combined with conventional DMARDs versus synthetic DMARDs (RR 1.08, 95% CI: 0.94-1.23). Conclusions: There is no difference in the outcome of remission in patients with early rheumatoid arthritis receiving biological therapy versus patients treated with conventional disease modifying antirheumatic drugseng
dc.format.mimetypeapplication/pdf
dc.identifier.doihttps://doi.org/10.1016/j.rcreu.2017.04.001
dc.identifier.instnameinstname:Universidad El Bosquespa
dc.identifier.issn2027-9000
dc.identifier.reponamereponame:Repositorio Institucional Universidad El Bosquespa
dc.identifier.repourlhttps://repositorio.unbosque.edu.co
dc.identifier.urihttps://hdl.handle.net/20.500.12495/3419
dc.language.isospa
dc.publisherAsociacion Colombiana de Reumatologiaspa
dc.publisher.journalRevista colombiana de reumatologiaspa
dc.relation.ispartofseriesRevista colombiana de reumatologia, 2027-9000, Vol. 24, Nro. 3, 2017, p. 164-176spa
dc.relation.urihttps://www.sciencedirect.com/science/article/abs/pii/S0121812317300439?via%3Dihub
dc.rights.accessrightshttps://purl.org/coar/access_right/c_abf2
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess
dc.rights.accessrightsAcceso abierto
dc.rights.creativecommons2017-04-06
dc.rights.localAcceso abiertospa
dc.subjectArtritis reumatoide tempranaspa
dc.subjectTerapia biológicaspa
dc.subjectRemisiónspa
dc.subject.decsrevisión sistemáticaspa
dc.subject.decsMortalidad prematuraspa
dc.subject.decsCalidad de vidaspa
dc.subject.keywordsEarly rheumatoid arthritisspa
dc.subject.keywordsBiological therapyspa
dc.subject.keywordsremissionspa
dc.titleBiological therapy in early rheumatoid arthritis: Efficacy in disease remissionspa
dc.title.translatedTerapia biológica en la artritis reumatoide temprana: eficacia en la remisión de la enfermedadspa
dc.type.coarhttps://purl.org/coar/resource_type/c_6501
dc.type.driverinfo:eu-repo/semantics/article
dc.type.hasversioninfo:eu-repo/semantics/publishedVersion
dc.type.localArtículo de revista

Archivos

Bloque original
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
enza Beatriz Camargo-Barriosa , Jorge Eliécer Rivas-Ibargüena , Gerardo Quintana-Lópezb_2017.pdf
Tamaño:
738.48 KB
Formato:
Adobe Portable Document Format
Descripción:
Descargar
Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descripción:
Descargar

Colecciones

Artículos